« Back
Home /
Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 14 (TNFSF14)

Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 14 (TNFSF14)

Manufacturer	Cloud-Clone
Category	Oncology Neuroscience Neuroinflammation Metabolism Diabetes Antibodies By Cell Type Cell Biology Obesity Cell Culture Cytokines Cell Status Necrosis Apoptosis Immunohistochemistry Immunoprecipitation Western Blot Immunocytochemistry Primary Antibodies
Type	Antibody Polyclonal
Specific against	Human
Applications	WB, IP, IHC, ICC
Amount	500ul
Host	Rabbit
Item no.	PAA827Hu01-500ul
Targets	TNFRSF14, TNF
eClass 6.1	32160702
eClass 9.0	32160702
Available
Alias	CD258, TR2, HVEML, LIGHT, LTg, Herpes virus entry mediator ligand, Herpesvirus entry mediator ligand
Quantity options
Alternative Names	CD258, TR2, HVEML, LIGHT, LTg, Herpes virus entry mediator ligand, Herpesvirus entry mediator ligand
Research Area	CD & Adhesion molecule, Apoptosis, Tumor immunity, Infection immunity,
Buffer Formulation	0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Immunogen	RPA827Hu01-Recombinant Tumor Necrosis Factor Ligand Superfamily, Member 14 (TNFSF14)
Usage	Western blotting: 0.5-2ug/mL; Immunohistochemistry: 5-20ug/mL; Immunocytochemistry: 5-20ug/mL; Optimal working dilutions must be determined by end user.
Traits	Liquid
Purification	Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.